Sonexa Therapeutics

Patient Resources

Sonexa successfully completed two Phase II Proof-of-Concept trials in Alzheimer’s disease.

For information on the completed clinical trials conducted with ST101, please see the following ClinicalTrials.gov links:

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

For additional information on Alzheimer's disease, please contact: